A research about probiotics for symptoms and gut microbiota of Irritable bowel syndrome

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017262

Enrollment

Unknown

Registered

2018-07-20

Start date

2018-09-01

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome

Interventions

Group A1:Probiotics

Group B1:Without probiotics

Group A2:Probiotics

Group B2:Without probiotics

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years old; 2. Patients meet the diagnostic criteria of IBS-D and IBS-C; 3. All people in both groups voluntarily joined this study with informed consents.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Women dont take any contraceptive measures; 3. Accompanied with severe primary diseases such as active malignant tumor, stroke, myocardial infarction and so on; 4. Patients with a history of abdominal surgeries; 5. Patients with a history of mental illness.

Design outcomes

Primary

Measure	Time frame
Blood inflammation markers;fecal microbiota;	—

Countries

China

Contacts

Public ContactXiaozhong Gao

Weihai Municipal Hospital

xzgaoweihai@sina.com18660378966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026